Cytochrome P450 2A5 (CYP2A5) oxidizes bilirubin to biliverdin and represents a putative candidate for maintaining bilirubin at safe but adequate antioxidant levels. Curiously, CYP2A5 is induced by both excessive heme and chemicals that inhibit heme synthesis. We hypothesized that heme homeostasis is a key modifier of Cyp2a5 expression via transcription factor nuclear factor erythroid-derived 2-like 2 (Nrf2) and characterized the coordination of CYP2A5 and heme oxygenase-1 (HMOX1) responses using wild-type and Nrf2(−/−) primary mouse hepatocytes. HMOX1 was rapidly elevated by exogenous hemin, thereby limiting the transactivation of Cyp2a5 until high heme (> 5µM) exposure. Nrf2 was mandatory for CYP2A5 but not for HMOX1 induction by heme. CYP2A5 was intensively and HMOX1 moderately elevated in heme synthesis blockades by succinylacetone and N-methyl protoporphyrin IX, and Nrf2 partially mediated the induction of CYP2A5. Immunoelectron microscopy revealed that CYP2A5 is targeted Nrf2 dependently both to the endoplasmic reticulum (ER) and mitochondria. However, excessive heme increased CYP2A5 predominantly in the ER. Phenobarbital, dibutyryl-cAMP, and peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) overexpression stimulate heme biosynthesis and induce CYP2A5. Acute but not chronic CYP2A5 induction by phenobarbital required Nrf2, whereas CYP2A5 induction by dibutyryl-cAMP and PGC-1α was potentiated by Nrf2 knockout. Collectively, heme homeostasis is established as a crucial regulator of hepatic Cyp2a5 expression mediated via Nrf2 activation, whereas Nrf2 is redundant for Hmox1 induction by heme. Similar subcellular targeting and coordination of CYP2A5 and HMOX1 responses suggest favorable conditions for enhanced CYP2A5-mediated bilirubin maintenance in altered heme homeostasis that predisposes to oxidative stress.
Heme is indispensable for all cellular metabolism involving oxygen transfer but detrimental if uncontrolled. in heme deficiency, translational events and progression of cell cycle cease, whereas high levels of free heme generate reactive oxygen species (ROs) and damage cellular structures (Acharya et al., 2010; Gozzelino et al., 2010) . Therefore, heme homeostasis needs to be tightly regulated via controlled expression of the rate-limiting biosynthetic enzyme aminolevulinic acid synthase-1 (ALAs1) and heme-catabolizing heme oxygenase-1 (HMOx1) (Wu et al., 2009) . in elevated heme conditions, the expression of ALAs1 is suppressed and HMOx1 is upregulated by heme-sensitive regulatory proteins (sun et al., 2002; Wu et al., 2009) . Besides elimination of toxic free heme, the catabolism of heme releases bioactive byproducts, harmful iron that is readily bound by ferritin, cO with antiproliferative and anti-inflammatory properties, and biliverdin, which is reduced to antioxidative and potentially toxic bilirubin by biliverdin reductase (Baranano et al., 2002; Pae et al., 2008) .
Bilirubin, an efficient scavenger of ROs (Jansen et al., 2010; stocker et al., 1987) , has a specific detoxification pathway via glucuronidation that prevents accumulation of bilirubin in high pro-oxidant concentrations (Baranano et al., 2002) . it has been hypothesized that bilirubin could involve an intracellular redox cycling system where bilirubin is first oxidized and then recovered by biliverdin reductase-mediated catalysis (Baranano et al., 2002) . collectively, the induction of HMOx1 that occurs in response to a wide variety of stimuli, such as heat shock, proinflammatory cytokines, and altered redox homeostasis, offers multiple solutions to confer cytoprotection in various cellular stress conditions (Pae et al., 2008) . interestingly, HMOx1 exhibits dual localization in the endoplasmic reticulum (ER) and mitochondria, with adaptive functions presented in and emanating from both compartments (Bindu et al., 2011; converso et al., 2006) .
Murine hepatic cytochrome P450 2A5 (cYP2A5) is elevated in parallel with HMOx1 in oxidative and electrophilic stress (Lämsä et al., 2010) . The induction of both genes is mediated by the activation of nuclear factor erythroid-derived 2-like 2 (Nrf2) pathway, which under homeostatic conditions is efficiently repressed by the cytoplasmic inhibitor Kelch-like EcH-associated protein 1 (Keap1) (Lämsä et al., 2010; Reichard et al., 2007) . However, the transactivation of HMOx1 requires derepression of BTB and cNc 1 homology 1 (Bach1) by heme or other molecules mimicking heme such as heavy metals (sun et al., 2004) , which permits the binding of Nrf2 as a heterodimer with small musculoaponeurotic fibrosarcoma proteins to the underlying antioxidant response element (ARE) (shan et al., 2006) . conversely, the expression of Cyp2a5 gene is activated by even the very low level of nuclear Nrf2 under basal conditions although further elevation occurs in stress-induced nuclear translocation of Nrf2 (Lämsä et al., 2010) . interestingly, cYP2A5 protein was recently shown to be stabilized by bilirubin and capable of oxidizing bilirubin to biliverdin with considerable affinity (Abu-Bakar et al., 2011) . Hence, Abu-Bakar et al. postulated cYP2A5 as an inducible bilirubin oxidase that may both prevent accumulation of bilirubin in high cytotoxic levels and delay its elimination. Recently, also the closely related human cYP2A6 enzyme was reported to metabolize bilirubin to biliverdin (Abu-Bakar et al., 2012) .
interrupted heme biosynthesis may cause cytotoxicity via accumulation of heme precursors. such porphyria attacks may occur, for instance, in heavy metal lead exposure and are commonly precipitated by fasting or drug-induced ALAs1 elevation in porphyria patients with inherited defects in the biosynthetic enzymes (Handschin et al., 2005) . Many of the porphyria types with variable patterns of precursor accumulation include an increased risk of liver damage or hepatocarcinogenesis (Bonkovsky, 2005) . A well-studied suspect for both neuro-and hepatotoxicity is δ-aminolevulinic acid (δ-ALA), capable of damaging nuclear and mitochondrial DNA, and lipids via ROs generation (Felitsyn et al., 2008; Onuki et al., 2004; Weiss et al., 2003) . conversely, hepatotoxic protoporphyrin ix accumulation has been reported to modify hepatic gene expression associated with cholestatic injury although oxidative processes might also play a role (Davies et al., 2005) . Because cYP2A5 is efficiently upregulated by Pbcl 2 (Lämsä et al., 2010) and several other porphyrinogenic substances (salonpää et al., 1995, 1997) and by heme arginate in mouse liver (salonpää et al., 1995) , we hypothesized that cYP2A5 might be generally upregulated in altered heme homeostasis via Nrf2 pathway activation by accumulated toxic heme precursors or elevated free heme. in this study, we provide evidence that cYP2A5 and HMOx1, which are coinduced in compromised redox homeostasis and have putative sequential functions in heme catabolism, are coordinately, but through different regulatory mechanisms, induced by heme intermediates and excessive heme levels.
MATERIALS AND METHODS
Materials. δ-ALA hydrochloride, dibutyryl-cAMP (db-cAMP), di methyl sulfoxide (DMsO), phenobarbital sodium salt (PB), and succinylacetone were purchased from sigma-Aldrich (st Louis, MO). Fe(iii) protoporphyrin ix chloride (hemin), co(iii) protoporphyrin ix chloride (coPP), N-Methyl protoporphyrin ix (NMPP), sn(iV) protoporphyrin ix dichloride (snPP), and Zn(ii) Protoporphyrin ix (ZnPP) were from Frontier scientific inc. (Logan, UT). Primary antibody rabbit anti-Nrf2 igG (sc-13032) was from santa cruz Biotechnology (santa cruz, cA), rabbit anti-HMOx1 igG (sPA895) from stressGen (Victoria, Bc, canada), and mouse anti-β-actin igG (A1978) from sigma-Aldrich. chicken anti-cYP2A5 igY has previously been described (Lämsä et al., 2010) . secondary antibodies with conjugated horse radish peroxidase were purchased as follows: goat anti-rabbit igG (sigma), sheep antimouse igG (Amersham Pharmacia Biotech, U.K.), and rabbit anti-chicken/ turkey igG (Zymed, san Francisco, cA).
Animals and primary hepatocyte cultures. Nrf2
(−/−) c57BL/6 mice (Jyrkkanen et al., 2008) with an icR/129sv background and undergone backcrossing with c57BL/6 mice for 10 generations were bred in National Laboratory Animal center (University of Eastern Finland, Finland). Nrf2 (−/−) and wild-type c57BL/6 (Harlan, Holland) mice were housed in temperaturecontrolled animal facilities at center of Experimental Animals (University of Oulu, Finland) with 12-h light/dark cycle and unlimited access to tap water and standard chow. Livers of cO 2 -terminated male mice, aged 6-8 months, were excised and slightly perfused with ice-cold 1× PBs (sigma-Aldrich) to flush out the blood and snap frozen in liquid nitrogen for total RNA extraction. The livers of male mice, aged 8-14 weeks, were perfused with collagenase solution (Worthington Biochemical co., Lakewood, NJ) and prepared for cell culture as previously described (Arpiainen et al., 2005) . isolated hepatocytes were seeded at the density of 1 × 10 6 cells per well on 6-well plates and 3 × 10 5 cells per well on 12-well plates (FALcON Polystyrene cell culture Dish; BD Biosciences, san Jose, cA). cultures were allowed to stabilize overnight before experimental chemical exposures or adenoviral transductions. Animal experiments were reviewed and approved by the National Animal Experiment Board.
Chemical treatments. control cells were maintained in culture medium alone or with added vehicle DMsO (≤ 0.1% [vol/vol] ). The porphyrin substances were dissolved in DMsO; succinylacetone, PB, and db-cAMP were dissolved in H 2 O. δ-ALA was dissolved in hepatocyte culture medium freshly before adding on cells. in porphyrin treatments, cells were treated with 1/5/10µM hemin, 1/10µM coPP, 10µM snPP, and 10µM ZnPP for 6 and 24 h as indicated. Heme biosynthesis modulators δ-ALA (0.2/1mM), succinylacetone (0.5/3mM), and NMPP (10µM) were added in wild-type and Nrf2 (−/−) hepatocyte cultures for 24 and 72 h with substances added in fresh culture medium on a daily basis. PB (1.5/2mM) and db-cAMP (25µM) were added in wild-type and Nrf2
(−/−) primary hepatocyte cultures for 24 and 72 h with PB added in fresh culture medium on a daily basis.
Adenoviral infections.
Vector constructions of recombinant adenovirus expressing mouse PGc-1α (Arpiainen et al., 2008) and adenoviruses expressing human Nrf2 (ad-Nrf2) and human Keap1 (ad-Keap1) (Lämsä et al., 2010) have been previously described. in the Nrf2 rescue experiment (Fig. 2B) , primary hepatocytes were adenovirally transduced with three multiplicity of infection (MOi) viral units for 4 h before subsequent treatments with hemin or coPP for 24 h. in the ad-Keap1 experiment (Fig. 6D ), Nrf2 levels were suppressed using 1 or 3 MOi of ad-Keap1 for 12 h before subsequent PB exposure as indicated. cultures that were transduced with 5 MOi dose of ad-PGc-1α were maintained for 72 h before sampling.
RNA isolation and cDNA synthesis. Total RNAs were extracted using Nucleospin RNA ii Kit (Macherey-Nagel, Düren, Germany) or with TRireagent (sigma-Aldrich) according to manufacturer's protocol, with subsequent treatment of RNAs with DNase (Promega, Madison, Wi). RNA extraction from liver tissue samples has been previously described in detail (Lämsä et al., 2010) . One microgram of total RNAs was converted to cDNA HMOx1 AND cYP2A5 iN HEME HOMEOsTAsis 133 in M-MLV reverse transcriptase (Promega) catalyzed reaction with added random hexaprimers (Roche Diagnostics, Mannheim, Germany) and stop RNase inhibitor (5 Prime, Hamburg, Germany).
Real-time qPCR. Relative gene expression levels were quantitated by the comparative ct (△△ct) method, using Faststart Universal sYBR Green Master Mix containing reference dye ROx (Roche Diagnostics) and Applied Biosystems 7399 Real-Time PcR system (Applied Biosystems, Foster city, cA). Reference gene 18s levels were used to normalize target gene levels. The target gene primers for peroxisome proliferator-activated receptor-γ coactivator-1α (PGc-1α) (Arpiainen et al., 2008) and others have been previously described (Lämsä et al., 2010) . Additionally, quantitation of ALAs1 mRNA was primed with 5′-tct tcc gca agg cca gtc t-3′ (forward) and 5′-tgg gct ttg agc agc ctc tt-3′ (reverse), and glucose-6-phosphatase (G6Pase) catalytic unit with 5′-cat caa tct cct ctg ggtgg-3′ (forward) and 5′-tgc tgt agt agt cgg tgt cc-3′ (reverse).
Extraction of cellular protein fractions. Nuclear and cytoplasmic protein extracts were prepared as previously described (Lämsä et al., 2010) . Briefly, extractions were started from 2 × 10 6 cells that were washed and scraped in ice-cold PBs with freshly added complete protease inhibitor cocktail (Roche Diagnostics), which was also used in the later steps. After lysis of cells by vortexing with igepal cA-630 (sigma), lysates were spinned at 12,000 × g for 30 s. supernatants were collected as cytoplasmic fractions, nuclear protein extraction was continued from the pelleted nuclei, and the protein contents of both cellular fractions were quantitated as earlier described (Lämsä et al., 2010) .
Western blot. Protein fractions were separated by sDs-PAGE using 12% (wt/vol) polyacrylamide for cytoplasmic fractions with 25 µg of protein added well and 10% (wt/vol) polyacrylamide for nuclear fractions with 15 µg of protein added well. separated proteins were transferred on polyvinylidene fluoride membrane (Millipore, Billerica, MA) for labeling with the following primary antibodies: anti-cYP2A5 (1:5000), anti-HMOx1 (1:1000, o/n at + 4°c), anti-β-actin (1:50000), or anti-Nrf2 (1:1000, o/n at + 4°c) in 5% (wt/vol) milk-Tris buffered saline-0.1% (vol/vol) Tween for 1 h at room temperature unless otherwise described. secondary antibodies were diluted 1:20000, and incubations were continued at room temperature for 1 h. Proteins were visualized using chemiluminescent Peroxidase substrate-1 (sigma-Aldrich), and optical densities of protein bands were measured using Quantity One software (Bio-Rad, Hercules, cA). chicken anti-cYP2A5 igY antibody recognizes two bands at approximately 50 kDa region with the lower band representing cYP2A5 as previously shown (Arpiainen et al., 2005) . Because the used anti-Nrf2 antibody identifies several protein bands above 60 kDa, the porphyrin-induced protein band was controlled using nuclear extracts from Nrf2 knockout livers and wildtype hepatocytes overexpressing adenoviral Nrf2 (data not shown).
Immunoelectron microscopy. Wild-type c57BL/6 mouse primary hepatocytes were treated with hemin (5µM) and snPP (10µM) or vehicle DMsO alone for 24 h. cultured hepatocytes were washed with PBs and fixed in 4% (wt/vol) paraformaldehyde-0.1M phosphate buffer-2.5% (wt/vol) sucrose for 1 h at room temperature, pelleted, and immersed in 12% (wt/vol) gelatin. The pellets were immersed in 2.3M sucrose and frozen in liquid nitrogen. Thin cryosections were cut with a Leica Ultracut Fc6 ultramicrotome, and sections were prepared for immunolabeling with incubation in 2% (wt/vol) gelatin-PBs then in 0.1% (wt/vol) glycine-PBs. Antibodies and gold conjugate were diluted in 1% (wt/vol) bovine serum albumin-PBs. sections were labeled with chicken anti-cYP2A5 igY (Lämsä et al., 2010) (1:1000) for 1 h before subsequent secondary labeling with rabbit anti-chicken igG (1:500) (Novus Biologicals, Littleton, cO) and, finally, with protein-A gold complex (size 10 nm, made after slot and Geuze, 1985) . The sections were embedded in methylcellulose and examined in a Philips cM100 transmission electron microscope (FEi co., Eindhoven, The Netherlands). images were captured by Morada ccD camera (Olympus soft imaging solutions GMBH, Munster, Germany). For the analysis of the relative subcellular distribution of cYP2A5 (Fig. 3D ), 30 randomized images were taken per each sample. The number of gold particles within mitochondrial and extramitochondrial areas was counted using the imageJ software (Rasband, W. s., imageJ, U.s. National institutes of Health, Bethesda, MD, http://imagej.nih.gov/ij/, 1997-2012), and results were reported as normalized values against the respective total sum of analyzed subcellular area. The sum of analyzed mitochondrial areas and the sum of analyzed extramitochondrial areas were very similar between different samples (± 10%).
Statistical analysis. statistical data analysis was done using sPss 16.0 for Windows. The comparison of means of two groups was done by student's t-test, whereas multiple groups were compared by one-way ANOVA followed by Dunnett's post hoc test. Alternatively, for comparison of multiple groups of non-normal distribution, Kruskal-Wallis ANOVA in combination with the Mann-Whitney U-test was used. Differences were considered statistically significant when p < 0.05.
RESULTS

Hemin and CoPP Induce CYP2A5 and HMOX1 Expression in Hepatocytes
We compared the effects of hemin, which is intracellularly reduced to heme, and stable analogue coPP on cYP2A5 and HMOx1 mRNA and protein expression. cultured c57BL/6 mouse primary hepatocytes were exposed to 1 and 10µM hemin or coPP, and changes in the mRNA expression were measured after 6 and 24 h and compared with DMsO-treated controls. As expected, HMOx1 mRNA was efficiently induced by hemin and was upregulated up to 30-fold by 10µM hemin after 6 h. However, the effect of hemin on HMOx1 was already much diminished at 24-h time point (Fig. 1A ). This may be due to reduced intracellular heme concentration because of rapid metabolism of heme by HMOx1. indeed, in contrast to 10µM hemin, 10µM coPP (stable heme analogue) was less efficient but a longer lasting inducer of HMOx1 (Fig. 1B) . The expression of cYP2A5 mRNA was significantly elevated (between five to sixfold) in response to 10µM hemin both at 6-and 24-h time points, whereas treatment of hepatocytes with 1µM hemin only led to transient cYP2A5 mRNA induction detectable after 6 h (Fig. 1A) . Treatment of cells with 1µM coPP elevated cYP2A5 mRNA to about similar extent as 1µM hemin, but, in contrast to hemin, the induction was still detectable after 24 h (Fig. 1B) . Moreover, an extensive, time-dependent increase in cYP2A5 mRNA expression of up to 43-fold was measured in response to 10µM coPP (Fig. 1B) . Therefore, as opposed to HMOx1, coPP was a stronger inducer of cYP2A5 than hemin.
As a control, we measured the effects of hemin and coPP also on two other cYP genes. in contrast to cYP2A5, the mRNA levels of cYP2B10 and cYP3A11 were suppressed by the porphyrin treatments. Especially in response to coPP, the expression of cYP2B10 and cYP3A11 was significantly downregulated, indicating that heme and other metalloporphyrins do not generally induce cYP expression (Figs. 1A and B) . The basal expression of all cYPs and HMOx1 was slightly but not significantly downregulated by the culturing for additional 18 h after the collection of samples at the 6-h time point (Fig. 1c) . These rather small changes are unlikely to affect the responses to hemin and coPP at the 6-and 24-h time points.
We next studied the effect of hemin and coPP on cYP2A5 and HMOx1 protein expression. Analysis of the cytoplasmic HMOx1 AND cYP2A5 iN HEME HOMEOsTAsis 135 protein fractions by Western blot indicated that both compounds equally induced cYP2A5 and HMOx1 protein expression after 24 h treatment (Fig. 1D) .
The aforementioned experiments suggest that the induction by hemin is limited by heme metabolism. To measure the effect of hemin on cYP2A5 and HMOx1 expression in the absence of inducible heme catabolism, hemin (5µM) was added to hepatocyte cultures alone or together with HMOx1 inhibitors snPP and ZnPP. Neither of the inhibitors alone affected HMOx1 expression, and cYP2A5 mRNA was only slightly elevated by ZnPP (Fig. 1E) . Five micromolars of hemin alone did not affect cYP2A5 or HMOx1 expression after 24 h treatment. However, when 5µM hemin was added together with HMOx1 inhibitors, cYP2A5 mRNA was elevated about 12-to 14-fold compared with samples treated with hemin alone (Fig. 1E) . Also HMOx1 was induced by cotreatment (Fig. 1E) . These results indicate that the enzymatic function of rapidly increasing HMOx1 limits the expression of HMOx1 itself, but also the induction of cYP2A5 by heme. Furthermore, this indicates that heme and none of the metabolic products mediate the induction.
Nrf2 Is Essential for the Induction of CYP2A5 but Not of HMOX1 by Hemin and CoPP
Nrf2 protein is readily guided to proteasomal degradation by its cytoplasmic sequestering protein Keap1 under homeostatic conditions, but alterations in the cellular redox conditions or exposure to antioxidant substances allow newly synthesized Nrf2 to translocate to the nucleus. To assess hemin and coPPmediated nuclear accumulation of Nrf2 in cultured mouse primary hepatocytes, nuclear protein fractions were extracted from chemically treated cells and analyzed using Western blot. Onehour treatment with coPP induced clear elevation in nuclear Nrf2, whereas similar treatment with hemin did not produce any appreciable effect ( Fig. 2A) .
in the next phase, we studied the involvement of Nrf2 in the induction of cYP2A5 and HMOx1 by hemin and coPP and utilized primary hepatocytes extracted from Nrf2 knockout mouse. cYP2A5 was virtually not induced by hemin or coPP in Nrf2 (−/−) cells (Fig. 2B) . On the other hand, HMOx1 induction was similar to the previously observed response in wild-type hepatocytes. To further establish the role of Nrf2, we rescued the knockout by using adenovirus-mediated reintroduction of Nrf2 (ad-Nrf2). To avoid nuclear accumulation of overexpressed Nrf2 in chemically untreated cells, Nrf2
(−/−) primary hepatocytes were transduced with low viral load using MOi 3 of ad-Nrf2 (or control ad-LacZ) for 4 h before subsequent chemical treatment with vehicle DMsO, 10µM hemin, or 10µM coPP for 24 h. Ad-LacZ control virus did not affect the responses of cYP2A5 or HMOx1 to hemin or coPP (Fig. 2B) . in contrast, restoration of Nrf2 expression rescued the induction of cYP2A5 mRNA by hemin and coPP (Fig. 2B) . HMOx1 induction was slightly intensified in coPP-treated cells but not in hemin-treated cells by ad-Nrf2 (Fig. 2B) . These results indicate that Nrf2 is essential for cYP2A5 induction by hemin and coPP, but not for that of HMOx1.
Dually Targeted CYP2A5 Is Maintained by Nrf2 Both in the ER and Mitochondria and Induced by Excessive Cellular Heme in the ER
Heme biosynthesis is divided between the cytosol and the mitochondrial cell compartment, and the final steps take place in the mitochondria. interestingly, heme-catabolizing HMOx1 also appears to be present and inducible in response to elevated cellular heme in both ER and mitochondria (converso et al., 2006) . Also biliverdin reductase is present in hepatic mitochondria (converso et al., 2006) , indicating local production of bilirubin. This would also suggest need for mitochondrial enzyme that restricts the accumulation of potentially toxic bilirubin levels. some previous studies have reported detection of cYP2A5 in the mitochondrial cell fraction by using enzymatic assays and Western immunoblotting (Genter et al., 2006; Honkakoski et al., 1988) . We used immunoelectron microscopy (iEM) to analyze the subcellular localization of cYP2A5. As a proof of antibody specificity, preimmunized chicken igY indicated no signal in iEM (data not shown). cYP2A5 label was detected in the ER, as expected, but also mitochondria showed considerable immunopositivity (Fig. 3A) . interestingly, small amount of label was occasionally found in close proximity of the plasma and nuclear membranes (data not shown).
We also studied whether heme affects the subcellular distribution of cYP2A5. Therefore, wild-type primary hepatocytes were treated with hemin (5µM) combined with HMOx1 inhibitor snPP (10µM) or vehicle DMsO alone for 24 h, and fixed cell samples were labeled with cYP2A5 antibody before subsequent examination by transmission electron microscopy. cYP2A5 immunopositivity was elevated by hemin/ snPP treatment (Fig. 3B) , but increased amount of label was only detected in the ER based on quantitation of the signal in iEM images (Fig. 3D) . Furthermore, we analyzed the effect of   FIG. 3 . iEM shows the localization of cYP2A5 in cultured wild-type and Nrf2 knockout c57BL/6 mouse primary hepatocytes. Wild-type cells were treated with vehicle DMsO (A) or cotreated with hemin (5µM) and snPP (10µM) for 24 h (B), and Nrf2 knockout primary hepatocytes were treated with vehicle DMsO (c). in DMsO-treated wild-type cells (A), the localization of cYP2A5 was detected in mitochondria (M) and ER (arrow) and, in hemin/snPP treated cells (B), the expression of cYP2A5 was enhanced more in the ER (arrow) than in mitochondria (M). in Nrf2 knockout cells (c), the expression of cYP2A5 was reduced in the ER (arrow) but even more dramatically in mitochondria (M). (D) Quantitation of the subcellular distribution of cYP2A5 in panels A-c (see Materials and Methods section). p values were assessed by the Mann-Whitney U-test.
HMOx1 AND cYP2A5 iN HEME HOMEOsTAsis Nrf2 knockout on cYP2A5 protein expression and localization: Nrf2 (−/−) hepatocytes showed strong reduction in cYP2A5 immunopositivity in both subcellular compartments (Fig. 3c) although the reduction in signal was more pronounced in mitochondria (Fig. 3D ). Altogether these results indicate that Nrf2 regulates cYP2A5 expression both in the ER and mitochondria in particular, whereas enhanced localization of cYP2A5 primarily occurs in the ER in response to excessive cellular heme.
Heme Synthesis Intermediates Induce CYP2A5 and HMOX1
Through Nrf2-Dependent and -Independent Mechanisms interruption of heme synthesis leads to accumulation of heme synthesis precursors with toxic effects (Fig. 4A) . At least some of these effects are connected to increased oxidative stress, possibly both directly due to chemical reactivity and indirectly via altered mitochondrial respiratory functions in heme deficiency (Monteiro et al., 1991; Wu et al., 2009) . We investigated whether disruption of heme biosynthesis affects cYP2A5 and HMOx1 expression and whether Nrf2 is involved. succinylacetone irreversibly inhibits ALA dehydratase (ALAD), resulting in restrained heme synthesis and accumulation of δ-ALA. Wild-type hepatocytes were treated with two different concentrations of succinylacetone for 24 and 72 h. cYP2A5 mRNA was very efficiently induced by the compound with maximal induction of 250-fold after 24-h treatment with 3mM succinylacetone (Fig. 4B) . Nrf2 knockout strongly attenuated but did not abolish the response after 24 h. Furthermore, after 72 h, Nrf2 knockout had no effect on
FIG. 4.
The expression of cYP2A5, HMOx1, PGc1α, and ALAs1 mRNAs in wild-type and Nrf2 knockout hepatocyte cultures with chemically modulated heme homeostasis. (A) scheme of heme biosynthesis pathway. The underlined enzymes were chosen as targets of inhibition using the inhibitor substances (panels B and D) specified in bold italics. The relative, 18s normalized mRNA expression levels of cYP2A5, HMOx1, PGc1α, and ALAs1 in response to treatments with inhibitor succinylacetone (B), heme biosynthesis intermediate δ-aminolevulinic acid (c), and inhibitor NMPP (D) for 24 and 72 h. Data in panels B-D represent mean + sD of three independent replicates presented as fold to respective untreated or DMsO-treated control. To assess intragroup p values (i.e., comparison of mean responses to the heme biosynthesis modulators within one group of hepatocytes of similar genotypic background and period of exposure time), one-way ANOVA combined with Dunnett's post hoc test was done ( ‡p ≤ 0.001; †p ≤ 0.01; #p < 0.05). To assess intergroup p values (i.e., comparison of means in response to a specific treatment by the different genotypic hepatocyte cultures), student's t-test was done (***p ≤ 0.001; **p ≤ 0.01; *p < 0.05).
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LÄMsÄ ET AL. cYP2A5 induction by succinylacetone (Fig. 4B) . HMOx1 was induced only twofold by succinylacetone, and the Nrf2 knockout had no effect on the induction (Fig. 4B) . ALAs1 catalyzing the first step in heme biosynthesis was induced by succinylacetone up to sixfold. This was dependent on Nrf2 with the higher concentration of succinylacetone (Fig. 4B) . Also coactivator PGc-1α, involved in the regulation of ALAs1 (Handschin et al., 2005) , was transiently induced by succinylacetone, but this was not dependent on Nrf2 (Fig. 4B) .
succinylacetone both inhibits heme production and increases cellular δ-ALA levels. in addition, this compound may have other unrelated affects. Therefore, we also studied the direct effects of δ-ALA administration. This treatment is expected to increase, besides cellular δ-ALA levels, also concentrations of other intermediates further downstream of the heme synthesis pathway and complete heme. Wild-type and Nrf2 (−/−) primary hepatocytes were treated with 0.2 and 1mM δ-ALA for 24 and 72 h. δ-ALA was less efficient inducer of cYP2A5 than succinylacetone, possibly because of conversion to heme. However, 72-h treatment with 0.2 and 1mM δ-ALA induced cYP2A5 10-and 14-fold, respectively. Most of the induction was lost in Nrf2 (−/−) cells (Fig. 4c) . HMOx1 was induced more powerfully by δ-ALA than succinylacetone. interestingly, Nrf2 knockout potentiated HMOx1 induction by δ-ALA (Fig. 4c) . ALAs1 was downregulated by δ-ALA (presumably as the result of negative feedback by enhanced heme synthesis), suggesting that the previously observed induction of ALAs1 by succinylacetone was unrelated to δ-ALA accumulation, but rather mediated by feedback mechanisms related to insufficient heme synthesis. PGc-1α was not affected by δ-ALA (Fig. 4c) .
NMPP is a competitive inhibitor of ferrochelatase and interrupts heme synthesis by blocking the terminal enzymatic step, which results in accumulation of protoporphyrin ix. cYP2A5 and HMOx1 were induced 70-and 7-fold, respectively, by 72-h treatment with 10µM NMPP, and this was attenuated by Nrf2 knockout (Fig. 4D) . Treatment with NMPP for 24 h had no effect on cYP2A5, but HMOx1 was induced about threefold (Fig. 4D) . curiously, Nrf2 knockout had an opposite effect on HMOx1 induction by NMPP after 24 h compared with 72 h. ALAs1 was induced about twofold by NMPP, which likely represents a compensatory response to heme deficiency (Fig. 4D) .
The Expression of ALAS1 mRNA Is Modified by Nrf2 Pathway
The effect of succinylacetone on ALAs1 appeared to be modulated by Nrf2 (Fig. 4B) . Therefore, we studied more closely whether regulation of ALAs1 involves Nrf2. Mouse primary hepatocytes were transduced with several doses of ad-Nrf2, and the effect on ALAs1 mRNA expression was measured. Fifty MOi of ad-Nrf2 induced ALAs1 expression statistically significantly in all time points studied at 24, 48, or 72 h, and maximal induction, about threefold, was observed after 48 h (Fig. 5A) . Also 10 MOi of ad-Nrf2 clearly increased ALAs1 mRNA after 48 h, but the effect was not statistically significant. We have previously reported that 50 MOi of ad-Nrf2 induces cYP2A5 and HMOx1 mRNAs 15-and 8-fold, respectively, after 48 h (Lämsä et al., 2010) . Therefore, the detected ALAs1 response is modest compared with these two established Nrf2 target genes. Finally, we studied whether constitutive ALAs1 mRNA expression in vivo was dependent on Nrf2 by studying the effect of Nrf2 knockout on ALAs1 expression. interestingly, average ALAs1 mRNA expression was about 50% lower in livers of Nrf2 (−/−) mice than wild-type mice (Fig. 5B) . These results suggest that hepatic Alas1 is moderately modulated by Nrf2/Keap1 pathway both in vitro and in vivo.
FIG. 5.
The expression of ALAs1 mRNA in response to modulation of Nrf2 expression. The relative, 18s normalized mRNA level of ALAs1 was (A) determined in response to adenoviral overexpression of Nrf2 in cultured wildtype primary hepatocytes that were exposed to viral doses of 3/10/50 MOi for 24, 48, or 72 h and (B) in the livers of wild-type and Nrf2 knockout c57BL/6 mice. Bars represent mean + sD of three independent replicates presented as fold to uninfected control or the respective expression level in wild-type livers. p values were assessed by one-way ANOVA combined with Dunnett's post hoc test (A) or student's t-test (B).
HMOx1 AND cYP2A5 iN HEME HOMEOsTAsis
The Role of Nrf2 in CYP2A5 Upregulation by Phenobarbital and cAMP/PGC-1α Pathway
Heme synthesis is stimulated by fasting through PGc-1α-mediated mechanisms (Handschin et al., 2005) . Also certain drugs such as phenobarbital activate heme synthesis by inducing ALAs1 expression (Handschin et al., 2005) . interestingly, these same factors also induce cYP2A5 expression raising the question whether increased cellular heme level could be involved in the regulation of cYP2A5 by fasting and phenobarbital. Because we found that Nrf2 is essential for cYP2A5 induction by heme, Nrf2 knockout should abolish the putative heme-mediated induction mechanisms.
Fasting induces PGc-1α primarily through cAMP-mediated mechanisms. Therefore, wild-type and Nrf2 knockout primary hepatocytes were treated with 25µM db-cAMP for 24 h, and the mRNA levels of cYP2A5, HMOx1, ALAs1, G6Pase, and PGc-1α were measured. Because PGc-1α is typically quickly and transiently induced by cAMP after 2-3 h (Arpiainen et al., 2008) , no PGc-1α induction was detected after 24-h treatment. However, PGc-1α target genes G6Pase and cYP2A5 were induced about four and twofold, respectively, by db-cAMP in wild-type hepatocytes (Fig. 6A) . interestingly, both of these genes were induced significantly more potently in db-cAMPtreated Nrf2 (−/−) cells (Fig. 6A) . ALAs1 was not induced by db-cAMP in wild-type cells. However, twofold induction of ALAs1 was detected in Nrf2 (−/−) cells (Fig. 6A) . Furthermore, HMOx1 was not affected by db-cAMP.
We next studied the direct effect of PGc-1α. Adenoviral overexpression of PGc-1α increased cYP2A5 mRNA expression about twofold in wild-type hepatocytes. in contrast, the same treatment in Nrf2 (−/−) cells led to a dramatic 160-fold elevation of cYP2A5 mRNA (Fig. 6B) . ALAs1 was induced about threefold by ad-PGc-1α, and the genotype had no effect (Fig. 6B ). G6Pase was measured as an additional control. G6Pase mRNA was induced 630-fold in wild-type but only 200-fold in Nrf2 (−/−) cells by ad-PGc-1α. Altogether, these
FIG. 6.
The expression of cYP2A5, cYP2B10, HMOx1, ALAs1, G6Pase, and PGc-1α mRNAs in wild-type and Nrf2 knockout cultures overexpressing PGc-1α or chemically treated with db-cAMP or phenobarbital. Relative mRNA levels after treatment with 25µM db-cAMP (A) for 24 h, infection of cells with control ad-LacZ or ad-PGc-1α virus (B) for 72 h, and treatment with 1.5mM PB (c) for 24 and 72 h are presented as fold to respective untreated (or uninfected) control values. Data (panels A-c) represent mean + sD of two or four independent replicates. (D) Wild-type cells were infected with 1 or 3 MOi doses of control ad-LacZ or ad-Keap1 for 12 h before induction with 2mM PB for 24 or 72 h. Data represent mean + sD of three independent replicates presented as fold to respective untreated control of the same adenoviral transduction group. student's t-test was used to compare mean responses to db-cAMP and PB treatments in (A, c), whereas the p values in response to adenoviral transductions in (B) were assessed by one-way ANOVA followed with Dunnett's post hoc test ( ‡p ≤ 0.001; †p ≤ 0.01; #p < 0.05). student's t-test was used to compare intergroup mean responses to a specific treatment by the different genotypic hepatocyte cultures (***p ≤ 0.001; **p ≤ 0.01; *p < 0.05).
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LÄMsÄ ET AL. results indicate that induction of Cyp2a5 by cAMP and PGc-1α is not mediated by increased heme synthesis and subsequent Nrf2 activation. in fact, the Nrf2 pathway appeared to suppress cAMP and PGc-1α induction of cYP2A5 mRNA. However, similar suppression was not observed for other PGc-1α target genes, i.e., ALAs1 and G6Pase.
We also studied the significance of Nrf2 pathway on phenobarbital-mediated induction of cYP2A5. in phenobarbitaltreated wild-type hepatocytes, cYP2A5 mRNA was increased about threefold both after 24-and 72-h exposure times. interestingly, no induction of cYP2A5 mRNA was observed in Nrf2 (−/−) hepatocytes treated for 24 h, whereas both genotypes showed similar induction after 72 h (Fig. 6c) . in contrast to cYP2A5, no significant differences could be detected in the induction levels of cYP2B10 in wild-type and Nrf2
(−/−) hepatocytes (Fig. 6c) . ALAs1 was modestly induced by phenobarbital after 24 h, whereas similar small induction of HMOx1 was detected after 72 h (Fig. 6c) . The time-dependent role of Nrf2 in cYP2A5 induction by phenobarbital was confirmed in another model. Wild-type primary hepatocytes were transduced with adenovirus overexpressing Keap1, a cytoplasmic inhibitor of Nrf2. Different doses, 3 MOi and 1 MOi of ad-Keap1, were respectively used in the time points of 24 and 72 h to compensate the longer exposure time with lower dose. However, both cultures showed abundant expression of human Keap1 (data not shown). Keap1 strongly attenuated cYP2A5 induction by phenobarbital after 24-h treatment but had no effect after 72-h exposure (Fig. 6D) . These results suggest that Nrf2 participates in the induction of cYP2A5 in acute but not in chronic phenobarbital exposure.
DISCUSSION
Heme is essential to cellular oxidative metabolism, but excessive free heme and heme intermediates that accumulate in impaired heme biosynthesis cause oxidative stress (Gozzelino et al., 2010; Monteiro et al., 1991) . in altered redox conditions, Nrf2 pathway is activated and adaptively upregulates the expression of HMOx1 and cYP2A5 that have putative sequential roles in heme catabolism and production of antioxidative bilirubin and reoxidization of bilirubin to biliverdin. The suggested endogenous significance of cYP2A5 as inducible bilirubin oxidase (Abu-Bakar et al., 2011) that may control the maintenance of cytoprotective bilirubin levels in cooperation with biliverdin reductase remains to be clarified. We approached this problem from the regulatory perspective and hypothesized that heme homeostasis is a key modulator of hepatic Cyp2a5 expression that adjusts the expression of Hmox1 and Cyp2a5 in parallel but distinctively by involvement of the ARE interacting repressor Bach1 and transcriptional activator Nrf2.
We compared the relative responses of the two heme catabolism-associated genes, Hmox1 and Cyp2a5, to elevated intracellular heme. HMOx1 was elevated by heme ahead of cYP2A5, but transiently in comparison with cYP2A5. Because of the efficient HMOx1 induction and subsequent rapid catabolism of heme, cYP2A5 was not significantly upregulated until very high heme concentrations (5-10µM) were present. However, physiologically neutral heme level is reported to be below 1µM (sassa, 2004) , and normal fluctuation in heme levels may occur at about the magnitude of fourfold (Wu et al., 2009 ) via strict regulation of the expression of ALAs1 and HMOx1. This suggests that heme is unlikely to affect the constitutive expression of Cyp2a5 and rather high bursts of free heme are needed to provoke cYP2A5 induction in parallel with elevated HMOx1. Furthermore, our results confirm that upregulation by heme is distinctive to cYP2A5 as the mRNA levels of the other studied cYPs were repressed by heme.
Cyp2a5 and Hmox1 are both activated by Nrf2, but Hmox1 induction requires derepression of repressor Bach1 before Nrf2 can bind to the same DNA element (shan et al., 2006; sun et al., 2002, 2004) . Also regulation of Hmox1 by heme is generally assumed to involve both Bach1 and Nrf2. However, our current results show that Hmox1 induction by heme does not require Nrf2, and restoration of Nrf2 expression in Nrf2 (−/−) cells enhanced Hmox1 induction very modestly by coPP and not at all by hemin. in fact, the involvement of Nrf2 in Hmox1 induction in hepatocytes has been formally shown for only coPP in human hepatoma Huh-7 cell line (shan et al., 2006) , and no similar evidence exists for heme. interestingly, the report by sun et al. (2002) on Hmox1 induction in bach1/nrf2 combined mutant mice with varying combinations of bach1 and nrf2 mutations indicated that the requirement of Nrf2 may be tissue specific with Nrf2 being redundant in the thymus and liver in comparison with lung and heart where the presence of Nrf2 was more critical. Nevertheless, Nrf2 was indispensable for Cyp2a5 induction by hemin and coPP, indicating that hepatic regulatory mechanisms of Hmox1 and Cyp2a5 by heme are different. Cyp2a5 is primarily regulated by Nrf2, whereas Hmox1 is mainly under the control of Bach1. Furthermore, our results support the idea that Bach1 is more sensitive heme sensor than Nrf2, which requires toxic heme levels for activation. On the contrary, heavy metals appear to activate Nrf2 more efficiently in parallel with Bach1 derepression (Lämsä et al., 2010; Reichard et al., 2007) .
We report here that heme-inducible HMOx1 expression efficiently limits the induction of cYP2A5 mRNA, as demonstrated by replacement of hemin with coPP and coadministration of hemin with HMOx1 inhibitors snPP and ZnPP. interestingly, other studies suggest that heme catabolism byproducts may support cYP2A5 induction. Firstly, liberated cO may enhance Nrf2 translocation (Pae et al., 2008) , which might partially explain the lingering Cyp2a5 induction in parallel with Hmox1. secondly, cYP2A5 protein is post-translationally stabilized by bilirubin (Abu-Bakar et al., 2011) . This may explain the observation that although coPP was much more powerful inducer of cYP2A5 mRNA than hemin, the two compounds upregulated cYP2A5 protein rather equally. The activation of Nrf2 pathway by heme HMOx1 AND cYP2A5 iN HEME HOMEOsTAsis and subsequent cYP2A5 induction are, thus, inherently coordinated via HMOx1 and by the sufficiency of heme catabolism.
Repressed heme biosynthesis elevated cYP2A5 more extensively than heme. Cyp2a5 induction was particularly pronounced by succinylacetone inhibiting ALAD and leading to extensive accumulation of free radical generating δ-ALA (Onuki et al., 2004; Weiss et al., 2003) , whereas Hmox1 was only modestly responsive to similar treatment. Previously, induction of cYP2A5 by porphyrinogenic stimulus has been noted by Davies et al. (2005) in protoporphyric BALB/c-Fech m1Pas mice and also by salonpää et al. (1995, 1997) with porphyrinogenic compounds griseofulvin, acifluorfen, aminotriazole, and thioacetamide. Accordingly, we have previously demonstrated that Pbcl 2 , a potent inhibitor of ALAD and ferrochelatase, is among the most efficient inducers of Cyp2a5 (Lämsä et al., 2010) . in the current study, we show that Nrf2 pathway mainly mediates cYP2A5 induction by the porphyrinogenic stimulus although additional regulators such as coactivator PGc-1α may also be involved. Elevated PGc-1α could increase Cyp2a5 directly via coactivation of HNF4α (Arpiainen et al., 2008) but also indirectly via induction of Alas1 and further production of δ-ALA (Handschin et al., 2005) . The role of parallel HMOx1 and cYP2A5 induction in heme synthesis blockades may seem unclear at first glance, but it may involve enhanced bilirubin formation from heme released by intracellular hemoproteins upon ROs-induced damage and/or heme deficiency involving ER stress (Acharya et al., 2010; Gozzelino et al., 2010; Waheed et al., 2010) . Accordingly, cYP2A5 induction in hepatotoxic conditions is often observed in conjuction with marked suppression of the activities and protein levels of several other cYPs (Abu-Bakar et al., forthcoming).
We observed that Alas1 transcription was subtly but consistently responsive to Nrf2 overexpression and significantly lowered in the livers of Nrf2 (−/−) mice. similar observations can also be made from previously published microarray data from Nrf2-deficient mice (Beyer et al., 2008) or mice with hepatocytespecific Keap1 deficiency (Osburn et al., 2008) . it is tempting to assume that ALAs1 expression might be fine tuned by Nrf2 in altered redox status to drive heme biosynthesis toward production of antioxidative bilirubin. On the other hand, it is not clear whether Alas1 is a direct Nrf2 target or perhaps indirectly regulated by altered heme levels.
Both HMOx1 and cYP2A5 enzymes have been reported to be dually targeted to the ER and mitochondria that also contain biliverdin reductase (converso et al., 2006; Honkakoski et al., 1988) . Our iEM assay confirmed that cYP2A5 is indeed detected in both subcellular compartments. However, although HMOx1 is induced in addition to the ER also in hepatic mitochondria by elevated intracellular heme (converso et al., 2006) , we observed that heme induces cYP2A5 preferably in the ER. importantly, Nrf2 was found to support the basal expression of cYP2A5 in both compartments, particularly in mitochondria. Mitochondria are especially vulnerable to ROs, and the close proximity of heme biosynthesis constitutes one source of ROs in perturbations of heme homeostasis. Under these conditions, cYP2A5-mediated oxidation may participate in local adjustment of bilirubin produced by HMOx1 and biliverdin reductase. Actually, cYP2A5 may putatively serve two functions in altered heme homeostasis: as a heme sequestering protein and through its enzymatic activity.
intact heme biosynthesis has been demonstrated as a prerequisite of efficient induction of Cyp2a5 transcription by phenobarbital, and transactivation of Cyp2a5 is disrupted within few hours of phenobarbital treatment in PBGD-deficient mice with limited heme synthesis (Jover et al., 2000) . Our current results demonstrate that heme regulates Cyp2a5 expression through Nrf2 pathway, suggesting that phenobarbital-activated heme synthesis could be involved in Cyp2a5 induction by phenobarbital. indeed, we observed poor induction of cYP2A5 by phenobarbital in Nrf2 knockout hepatocytes after acute 24-h phenobarbital exposure. Nevertheless, Hmox1 was poorly induced, suggesting that heme elevation may not fully explain Cyp2a5 induction by phenobarbital. interestingly, phenobarbital has been shown to elevate ROs production and activate an ARE reporter system in vivo in mice (Dostalek et al., 2008) , suggesting that Nrf2 may be activated by phenobarbital independently from heme synthesis. According to our studies, Nrf2 is dispensable for cYP2A5 induction in repeated phenobarbital exposure. Therefore, the later stage response may be mediated by other mechanisms, including the nuclear receptor constitutive androstane receptor (Wei et al., 2002) . We furthermore studied whether cAMP and PGc-1α, also inducing heme synthesis, involve Nrf2 in Cyp2a5 induction. This was found not to be the case. On the contrary, significantly elevated Cyp2a5 induction by overexpressed PGc-1α and cAMP was observed in Nrf2 (−/−) hepatocytes. This suggests novel cross talk between Nrf2 and PGc-1α. interestingly, both pathways are involved in cellular defence against oxidative stress (st Pierre et al., 2006) . in summary, these results demonstrate heme homeostasis as a major regulator of Cyp2a5 expression and establish the essential role of transcription factor Nrf2, which maintains the constitutive expression of cYP2A5 in the ER and mitochondria. Furthermore, we show that HMOx1 and cYP2A5 are coordinately regulated by heme but through different mechanisms, which supports their sequential activation by increasing heme levels that require incremental adaptive strategies. Under these conditions, cYP2A5 expression is predominantly enhanced in the ER. Together with the recently discovered cYP2A5-mediated oxidation of bilirubin to biliverdin (Abu-Bakar et al., 2011) , these findings suggest a putative endogenous function for cYP2A5 in the maintenance of cellular bilirubin homeostasis and oxidative balance.
